Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Gastrointestinal Over-The-Counter (OTC) Drugs Industry Expected To Reach By 2029, Starting From 2025 Levels?
The gastrointestinal over-the-counter (OTC) drugs market has seen substantial expansion in recent years. This market is projected to increase from $45.73 billion in 2024 to $49.59 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.4%. The historical growth of this market can be linked to the increasing occurrence of gastrointestinal conditions, a greater consumer inclination towards self-medication, the wider availability of OTC proton pump inhibitors, a heightened awareness regarding digestive health, and the growing elderly population susceptible to GI problems.
The gastrointestinal over-the-counter (otc) drugs market is projected to experience substantial expansion in the coming years. This market is forecast to reach $67.88 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.2%. This anticipated growth during the forecast period can be ascribed to several factors, including a rising demand for quick symptom relief solutions, increased presence of e-commerce pharmacies, wider access to combination OTC treatments, a heightened emphasis on gut microbiome well-being, and enhanced marketing and public awareness initiatives by leading companies. Key trends expected during this period involve progress in developing fast-acting antacid formulations, novel probiotic-based OTC products, the incorporation of herbal components into digestive remedies, improvements in packaging for precise dosing and ease of transport, and breakthroughs in sustained-release gastrointestinal therapies.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24547&type=smp
Which Drivers Are Supporting Growth Of The Gastrointestinal Over-The-Counter (OTC) Drugs Market?
The rising occurrence of digestive issues is projected to fuel the expansion of the gastrointestinal OTC drugs market in the future. These disorders encompass various ailments impacting the gastrointestinal tract, such as the stomach, intestines, and related organs. This surge in digestive problems primarily stems from increased consumption of processed, low-fiber diets, which negatively affect gut health and hinder digestion. Gastrointestinal OTC medications alleviate symptoms of digestive disorders by decreasing stomach acid, normalizing bowel function, and improving overall gut well-being. These drugs offer rapid and convenient relief for frequent problems such as acidity, constipation, and indigestion. A relevant example is from December 2023, where the IBD Registry Ltd., a UK non-profit organization, reported over 5,300 individuals with inflammatory bowel disease (IBD), an increase of more than 3,000 members from 2022. Consequently, the growing incidence of digestive ailments is a key factor boosting the gastrointestinal OTC drugs market.
What Are The Major Segment Categories Driving The Gastrointestinal Over-The-Counter (OTC) Drugs Market Growth?
The gastrointestinal over-the-counter (OTC) drugs market covered in this report is segmented –
1) By Product: Antacid, Laxatives, Anti-Diarrheal, Anti-Emetics, Other Products
2) By Formulation: Tablets, Capsules, Liquids, Other Formulations
3) By Indications: Heartburn, Diarrhoea, Constipation, Gastroesophageal Reflux Disease (GERD), Nausea, Vomiting, Motion Sickness, Other Indications
4) By Distribution Channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Clinics, Home Healthcare, Other End-Users
Subsegments:
1) By Antacid: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Calcium Carbonate, Magnesium Hydroxide, Sodium Bicarbonate, Combination Antacids
2) By Laxatives: Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxatives, Stool Softeners, Lubricant Laxatives
3) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, Probiotics, Electrolyte Solutions
4) By Anti-Emetics: Antihistamines, Bismuth Subsalicylate, Phosphorated Carbohydrate Solution, Ginger Supplements
5) By Other Products: Digestive Enzymes, Antispasmodics, Simethicone, Herbal Remedies, Activated Charcoal
What Key Innovation Trends Are Fueling Advancements In The Gastrointestinal Over-The-Counter (OTC) Drugs Market?
Major companies operating in the gastrointestinal OTC drugs market are concentrating on creating advanced offerings, including OTC proton pump inhibitors, to deliver potent and sustained relief for acid-related conditions. Over-the-counter (OTC) proton pump inhibitors (PPIs) are a category of non-prescription drugs that work by decreasing stomach acid production. These are frequently utilized for managing issues like persistent heartburn, acid reflux (GERD), and gastric ulcers. A notable example is in March 2025, when Eisai Co., Ltd., a pharmaceutical firm based in Japan, secured approval in Japan to transition its Pariet S (rabeprazole sodium 10 mg) from prescription (RX) to over-the-counter (OTC) availability, making it the initial OTC PPI in Japan with the identical active ingredient and dosage as its prescription version. Pariet S is prescribed for stomach discomfort, heartburn, and bloating, providing 24-hour relief through a once-daily, easy-to-take tablet, and seeks to fulfill the increasing demand for effective treatments for gastric acid issues stemming from evolving lifestyles and demographics.
Who Are The Major Companies Operating In The Gastrointestinal Over-The-Counter (OTC) Drugs Market?
Major companies operating in the gastrointestinal over-the-counter (OTC) drugs market are Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Boehringer Ingelheim GmbH, Haleon plc, Sandoz AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy’s Laboratories Ltd.
Download The Full Report For Exclusive Market Findings:
Which Region Is Projected To Lead The Gastrointestinal Over-The-Counter (OTC) Drugs Market During The Forecast Period?
North America was the largest region in the gastrointestinal over-the-counter (OTC) drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal over-the-counter (OTC) drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Gastrointestinal Over-The-Counter (OTC) Drugs Market Report:
https://www.thebusinessresearchcompany.com/customise?id=24547&type=smp
Browse Through More Reports Similar to the Global Gastrointestinal Over-The-Counter (OTC) Drugs Market 2025, By The Business Research Company
Colorectal Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report
Otc Drug And Dietary Supplement Global Market Report 2025
Gastroparesis Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model